LARIAM TAB 250MG 250 MG
MEFLOQUINE (MEFLOQUINE HYDROCHLORIDE) : 250 MG · DIN 02018055 · HOFFMANN-LA ROCHE LIMITED
Health Canada status: CANCELLED POST MARKET
What is LARIAM TAB 250MG?
LARIAM TAB 250MG 250 MG contains MEFLOQUINE (MEFLOQUINE HYDROCHLORIDE) : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02018055, held by HOFFMANN-LA ROCHE LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 02-May-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LARIAM TAB 250MG used for?
LARIAM (mefloquine) is indicated for the prophylaxis of P. falciparum and P. vivax malaria infections, including prophylaxis of chloroquine-resistant strains of P. falciparum. LARIAM is indicated for the treatment of mild to moderate acute malaria caused by mefloquine-susceptible strains of P. falciparum (both chloroquine-susceptible and resistant strains) or by P. vivax.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is LARIAM TAB 250MG called?
The same molecule, MEFLOQUINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Lariam | Latin | South Africa |
| Mefliam | Latin | South Africa |
| MEPHAQUIN LACTAB | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02018055 |
|---|---|
| Brand name | LARIAM TAB 250MG |
| Generic / active ingredient | MEFLOQUINE (MEFLOQUINE HYDROCHLORIDE) : 250 MG |
| Manufacturer | HOFFMANN-LA ROCHE LIMITED |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | P01BC02 MEFLOQUINE |
| AHFS class | 08:30.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-May-2013 |
| Original market date | 1993-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02018055 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2018055 |
| Brand name | LARIAM TAB 250MG |
| Active ingredient / INN | MEFLOQUINE (MEFLOQUINE HYDROCHLORIDE) : 250 MG |
| ATC code | P01BC02 |
| ATC anatomical main group | P — Antiparasitic products, insecticides and repellents |
| ATC therapeutic subgroup | P01 |
| AHFS class | 08:30.08 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | HOFFMANN-LA ROCHE LIMITED |
How is it stored and handled?
null
How is it supplied?
null
Which pack is which?
| Strength on the label | 250 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Packaging as described in the monograph | null |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code P01BC02 MEFLOQUINE. 1 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MEFLOQUINE | 250 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02244366 |
Who else supplies MEFLOQUINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MEFLOQUINE appears in 7 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does MEFLOQUINE cost around the world?
MEFLOQUINE is listed on 3 national price registers Nexara tracks, across 8 pack listings published on 3 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 1 | 3 | 03 Sep 2026 |
| South Africa | single exit price | 2 | 3 | 01 Sep 2026 |
| Saudi Arabia | public | 2 | 2 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.